380 related articles for article (PubMed ID: 25773046)
1. The effect of teriparatide to alleviate pain and to prevent vertebral collapse after fresh osteoporotic vertebral fracture.
Tsuchie H; Miyakoshi N; Kasukawa Y; Nishi T; Abe H; Segawa T; Shimada Y
J Bone Miner Metab; 2016 Jan; 34(1):86-91. PubMed ID: 25773046
[TBL] [Abstract][Full Text] [Related]
2. Effect of teriparatide (rh-PTH 1-34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study.
Iwata A; Kanayama M; Oha F; Hashimoto T; Iwasaki N
BMC Musculoskelet Disord; 2017 Apr; 18(1):148. PubMed ID: 28388910
[TBL] [Abstract][Full Text] [Related]
3. The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.
Hadji P; Zanchetta JR; Russo L; Recknor CP; Saag KG; McKiernan FE; Silverman SL; Alam J; Burge RT; Krege JH; Lakshmanan MC; Masica DN; Mitlak BH; Stock JL
Osteoporos Int; 2012 Aug; 23(8):2141-50. PubMed ID: 22159672
[TBL] [Abstract][Full Text] [Related]
4. Preventive effects of conservative treatment with short-term teriparatide on the progression of vertebral body collapse after osteoporotic vertebral compression fracture.
Park JH; Kang KC; Shin DE; Koh YG; Son JS; Kim BH
Osteoporos Int; 2014 Feb; 25(2):613-8. PubMed ID: 23943161
[TBL] [Abstract][Full Text] [Related]
5. Comparison of once-weekly teriparatide and alendronate against new osteoporotic vertebral fractures at week 12.
Ikeda S; Nakamura E; Narusawa K; Fukuda F; Matsumoto H; Nakai K; Sakata T; Yoshioka T; Fujino Y; Sakai A;
J Bone Miner Metab; 2020 Jan; 38(1):44-53. PubMed ID: 31297652
[TBL] [Abstract][Full Text] [Related]
6. Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study.
Kawabata A; Yoshii T; Hirai T; Ushio S; Kaito T; Yamashita T; Fujiwara H; Nagamoto Y; Matsuoka Y; Suzuki H; Nishimura H; Terai H; Tamai K; Tagami A; Yamada S; Adachi S; Watanabe K; Katsumi K; Ohashi M; Shibuya Y; Harimaya K; Kawaguchi K; Yokoyama N; Oishi H; Doi T; Kimura A; Inoue H; Inoue G; Miyagi M; Saito W; Nakano A; Sakai D; Nukaga T; Ikegami S; Shimizu M; Futatsugi T; Ohtori S; Furuya T; Orita S; Imagama S; Ando K; Kobayashi K; Kiyasu K; Murakami H; Yoshioka K; Seki S; Hongo M; Kakutani K; Yurube T; Aoki Y; Oshima M; Takahata M; Iwata A; Endo H; Abe T; Tsukanishi T; Nakanishi K; Watanabe K; Hikata T; Suzuki S; Isogai N; Okada E; Funao H; Ueda S; Shiono Y; Nojiri K; Hosogane N; Ishii K
BMC Musculoskelet Disord; 2020 Jul; 21(1):420. PubMed ID: 32611386
[TBL] [Abstract][Full Text] [Related]
7. Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
Jeon S; Yu D; Kim S; Kim SW; Jeon I
Osteoporos Int; 2024 May; 35(5):795-804. PubMed ID: 38261013
[TBL] [Abstract][Full Text] [Related]
8. Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications.
Zhao Y; Xue R; Shi N; Xue Y; Zong Y; Lin W; Pei B; Sun C; Fan R; Jiang Y
Osteoporos Int; 2016 Nov; 27(11):3309-3317. PubMed ID: 27245056
[TBL] [Abstract][Full Text] [Related]
9. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.
Tsuchie H; Miyakoshi N; Iba K; Kasukawa Y; Nozaka K; Dohke T; Kosukegawa I; Aizawa T; Maekawa S; Abe H; Takeshima M; Tomite T; Segawa T; Ouchi K; Kinoshita H; Suzuki M; Yamashita T; Shimada Y
Osteoporos Int; 2018 Dec; 29(12):2659-2665. PubMed ID: 30105400
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty.
Su CH; Tu PH; Yang TC; Tseng YY
J Spinal Disord Tech; 2013 Jun; 26(4):200-6. PubMed ID: 22134732
[TBL] [Abstract][Full Text] [Related]
11. Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study.
Ohtori S; Inoue G; Orita S; Yamauchi K; Eguchi Y; Ochiai N; Kishida S; Kuniyoshi K; Aoki Y; Nakamura J; Ishikawa T; Miyagi M; Kamoda H; Suzuki M; Kubota G; Sakuma Y; Oikawa Y; Inage K; Sainoh T; Takaso M; Ozawa T; Takahashi K; Toyone T
Spine (Phila Pa 1976); 2012 Nov; 37(23):E1464-8. PubMed ID: 22872218
[TBL] [Abstract][Full Text] [Related]
12. [Teriparatide for conservative treatment of osteoporotic vertebral fracture: analysis of 12 cases].
Yang DH; Hu SY; Meng Y; Tong GJ; Chen JT
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):414-8. PubMed ID: 27063174
[TBL] [Abstract][Full Text] [Related]
13. Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial.
Sugimoto T; Shiraki M; Nakano T; Kishimoto H; Ito M; Fukunaga M; Hagino H; Sone T; Kuroda T; Nakamura T
Curr Med Res Opin; 2013 Mar; 29(3):195-203. PubMed ID: 23259702
[TBL] [Abstract][Full Text] [Related]
14. Treatment of repeated and multiple new-onset osteoporotic vertebral compression fractures with teriparatide.
Tu PH; Liu ZH; Lee ST; Chen JF
J Clin Neurosci; 2012 Apr; 19(4):532-5. PubMed ID: 22341147
[TBL] [Abstract][Full Text] [Related]
15. Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk.
Nakamura T; Sugimoto T; Nakano T; Kishimoto H; Ito M; Fukunaga M; Hagino H; Sone T; Yoshikawa H; Nishizawa Y; Fujita T; Shiraki M
J Clin Endocrinol Metab; 2012 Sep; 97(9):3097-106. PubMed ID: 22723322
[TBL] [Abstract][Full Text] [Related]
16. Teriparatide Treatment in Elderly Patients With Sacral Insufficiency Fracture.
Yoo JI; Ha YC; Ryu HJ; Chang GW; Lee YK; Yoo MJ; Koo KH
J Clin Endocrinol Metab; 2017 Feb; 102(2):560-565. PubMed ID: 27880077
[TBL] [Abstract][Full Text] [Related]
17. Use of teriparatide in osteoporotic fracture patients.
Collinge C; Favela J
Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
[TBL] [Abstract][Full Text] [Related]
18. Effect of an intensive conservative therapy with daily teriparatide administration and rehabilitation for osteoporotic delayed vertebral collapse and paralysis.
Wakao N; Takeuchi M; Riew DK; Hirasawa A; Imagama S; Kawanami K; Matsuo T; Murotani K; Deie M
Medicine (Baltimore); 2018 Jun; 97(23):e10906. PubMed ID: 29879028
[TBL] [Abstract][Full Text] [Related]
19. Reduction in vertebral fracture risk in teriparatide-treated postmenopausal women as assessed by spinal deformity index.
Genant HK; Siris E; Crans GG; Desaiah D; Krege JH
Bone; 2005 Aug; 37(2):170-4. PubMed ID: 15961357
[TBL] [Abstract][Full Text] [Related]
20. At least one cyclic teriparatide administration can be helpful to delay initial onset of a new osteoporotic vertebral compression fracture.
Suk KS; Lee HM; Moon SH; Kim HJ; Kim HS; Park JO; Lee BH
Yonsei Med J; 2014 Nov; 55(6):1576-83. PubMed ID: 25323894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
